NFKB1 and Alzheimer disease: At the pathway level, inflammatory- and immune-related functions, like interferon α and γ response and TNFα signaling via NF-κB, are down-regulated across multiple AD phenotypes, but not in aging (Fig. 2e, Supplementary Fig. 5a-b).